References

Visual acuity outcomes and anti-vascular endothelial growth factor therapy intensity in neovascular age-related macular degeneration patients: a real-world analysis of 49 485 eyes

10.1016/j.oret.2019.05.017 · 2020 · External reference

Silicone oil droplets following intravitreal injection

10.1097/00006982-200607000-00021 · 2006 · External reference

Intravitreal silicone oil droplets after intravitreal drug injections

10.1097/iae.0b013e31816c6868 · 2008 · External reference

Prevalence of silicone oil droplets in eyes treated with intravitreal injection

10.1186/s40942-019-0184-9 · 2019 · External reference

Silicone microbubbles after anti‐vascular endothelial growth factor injections in patients with wet age‐related macular degeneration: incidence, quantification and secondary optical coherence tomography artfacts

10.1111/aos.14743 · 2021 · External reference

Prevalence and implications of the presence of intraocular silicone oil droplets in patients treated with intravitreal injections of anti-VEGF

10.1186/s12886-022-02536-2 · 2022 · External reference

Intravitreal silicone oil with a silicone-free versus a siliconized syringe

10.1016/j.oret.2024.09.008 · 2025 · External reference

Incidence of presumed silicone oil droplets in the vitreous cavity after intravitreal bevacizumab injection with insulin syringes

10.1001/jamaophthalmol.2017.1815 · 2017 · External reference

Silicone oil droplets following intravitreal bevacizumab injections

10.1016/j.ajoc.2017.07.009 · 2018 · External reference

Large silicone droplets after intravitreal bevacizumab (avastin)

10.1097/icb.0000000000000570 · 2019 · External reference

Cluster of symptomatic silicone oil droplets following intravitreal injections: a 1-year observational study

10.1136/bmjophth-2021-000764 · 2021 · External reference

SCORE study report 7: incidence of intravitreal silicone oil droplets associated with Staked-on versus luer cone syringe design

10.1016/j.ajo.2009.06.004 · 2009 · External reference

Silicone oil microdroplets and protein aggregates in repackaged bevacizumab and ranibizumab: effects of long-term storage and product mishandling

10.1167/iovs.10-6431 · 2011 · External reference

Critical analysis of techniques and materials used in devices, syringes, and needles used for intravitreal injections

10.1016/j.preteyeres.2020.100862 · 2021 · External reference

Silicone migration from Baked-on silicone layers. Particle characterization in placebo and protein solutions

10.1016/j.xphs.2016.08.031 · 2016 · External reference

Particulate matter from syringes used for intravitreal injections

10.1097/iae.0000000000002947 · 2021 · External reference

Prefilled syringes for intravitreal drug delivery

10.2147/opth.s169044 · 2019 · External reference

Variables impacting silicone oil migration and biologics in prefilled syringes

10.1016/j.xphs.2023.05.017 · 2023 · External reference

Accuracy, precision, and residual volume of commonly used syringes for intravitreal injections and the impact on intraocular pressure

10.1016/j.oret.2023.06.003 · 2023 · External reference

High particle variability across siliconized and oil-free syringes and needles from the same lots

10.1038/s41598-021-84158-0 · 2021 · External reference

Prospective study of silicone oil microdroplets in eyes receiving intravitreal anti-vascular endothelial growth factor therapy in 3 different syringes

10.1016/j.oret.2020.07.021 · 2021 · External reference

Experimental visualization and quantification of vitreous contamination following intravitreal injections

10.1097/iae.0000000000001028 · 2016 · External reference

Agitation of the syringe and release of silicone oil

10.1038/s41433-020-0800-9 · 2020 · External reference

Ocular inflammation after agitation of siliconized and silicone oil-free syringes: a randomized, double-blind, controlled clinical trial

10.1186/s40942-022-00387-z · 2022 · External reference

Persistent ocular hypertension following intravitreal ranibizumab

10.1007/s00417-008-0819-2 · 2008 · External reference

Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents

10.1136/bjo.2010.180729 · 2011 · External reference

Sustained intraocular pressure elevation after intravitreal injection of bevacizumab and ranibizumab associated with trabeculitis

10.2174/1874364101004010028 · 2010 · External reference

Sustained increased intraocular pressure related to intravitreal antivascular endothelial growth factor therapy for neovascular age-related macular degeneration

10.1097/ijg.0b013e31820d7d19 · 2012 · External reference

In vivo analysis of the potency of silicone oil microdroplets as immunological adjuvants in protein formulations

10.1002/jps.24573 · 2015 · External reference

Postmarketing analysis of aflibercept-related sterile intraocular inflammation

10.1001/jamaophthalmol.2014.5650 · 2015 · External reference

Sterile endophthalmitis after intravitreal injection of bevacizumab obtained from a single batch

10.1097/iae.0b013e3181bd2d51 · 2010 · External reference

Polymeric microneedles for the eye: an overview of advances and ocular applications for minimally invasive drug delivery

10.1016/j.ejpb.2024.114209 · 2024 · External reference